Annual Meeting
Year-Round
Resources
Collectives
The American Urological Association (AUA) is aware of the myriad of challenges that exist in launching and moving clinical trials forward in urology. We are committed to working with our partners and the community at large to find efficient and impactful ways of improving the process from beginning to end so that we can expedite discovery into clinical care and enhance the lives of our patients. This document focuses on the awareness and engagement piece of the challenge. We believe these new programs will elevate the awareness, understanding, and discussion around clinical trials in urology and place this important conversation at the heart of our community, reaching urologists, the entire health care team, and patients.
AUA Clinical Trials Collective (AUACTC)
2026 Focus: Securing the Future of Urologic Clinical Trials Amidst Declining Government Funding
Overview
In 2026, the AUACTC is turning its attention to one of the most urgent threats facing clinical research: reduced government funding for clinical trials. Without action, critical studies face delay or cancellation, threatening innovation, patient access, and research equity.
AUACTC will lead a national conversation on how the urology community can respond with sustainable solutions, new partnership models, and systems-level reform.
2024–2025 Achievements
In its first two years, the AUACTC focused on:
  • Addressing site-level resource constraints
  • Developing clinical trial navigator strategies
  • Increasing physician awareness and referrals
  • Promoting diversity in trial participation
2026 Strategic Focus Areas
1. Confronting Reduced Federal Funding
  • Analyze current NIH and agency investment trends
  • Assess impact on trial timelines and diversity
  • Explore public-private partnerships and consortium funding
2. Sustainability Planning
  • Design long-term models for trial infrastructure support
  • Protect academic and investigator-initiated research
3. Workforce & Infrastructure Development
  • Advance navigator training programs
  • Evaluate staffing challenges and propose scalable solutions
4. Advocacy & Policy Integration
  • Align efforts with AUA’s policy and advocacy agenda
  • Develop communication tools for policymakers and stakeholders
2026 Meeting Cadence
  • Spring (AUA Annual Meeting, In Person): Strategy sessions on funding, partnerships, and infrastructure
  • Summer (Virtual): Share research findings and develop recommendations
  • Fall (Virtual): Finalize direction and outline potential 2027 activities
2026 Potential Deliverables
Final outputs will be determined by AUACTC members based on discussions and priorities identified throughout the year. Potential areas of focus may include:
  • Landscape analysis of clinical trial funding trends
  • Concepts for sustainable funding or partnership models
  • Tools or resources to support trial sites and infrastructure
  • Policy briefs or communication materials for stakeholders
2026 Industry Membership
$50K per 2 seats/year (annual membership)
AUACTC remains a member-driven initiative—its direction and deliverables will reflect the insights, goals, and collaboration of the full collective.
AUA Precision Medicine Collective (AUAPMC)
2026 Launch: Advancing the Integration of Precision Medicine in Urologic Care
AUAPMC Makeup
  • 1 Chair (AUA member with precision medicine expertise)
  • 12 Core Physician Members (academic and community-based, with biomarker/genomic experience)
  • Industry Members (up to 2 seats per company via sponsorship)
  • AUA Staff Liaison (Office of Education)
Mission Statement
The AUA Precision Medicine Collective (AUAPMC) is dedicated to advancing the thoughtful integration of precision medicine into urologic care by identifying real-world barriers, supporting clinician education, and promoting equitable access to biomarker-driven and genomically-informed treatment strategies. Through collaboration among urologists, industry, and thought leaders, the AUAPMC will shape a scalable roadmap to enhance outcomes for patients across all practice settings.
Focus Areas
1. Biomarker Utilization
  • Identify gaps in guideline-based biomarker use
  • Develop strategies for clinical adoption
2. Genetic and Genomic Testing
  • Evaluate provider knowledge and barriers
  • Support integration of germline and somatic testing into workflows
3. Personalized Medicine in Practice
  • Explore implementation in bladder and prostate cancer
  • Compare across academic and community settings
4. Implementation Challenges
  • Address infrastructure gaps and access disparities
  • Focus on knowledge gaps in underserved populations
2026 Meeting Schedule
  • Spring (May): In-person at the AUA Annual Meeting
  • Summer: Virtual meeting
  • Fall: Virtual meeting
Needs Assessment
All AUAPMC strategies will be informed by a comprehensive needs assessment including:
  • One-on-one interviews with industry liaisons
  • Literature review of trends and data
  • National survey of AUA urologists and APPs
Findings will be shared exclusively with AUAPMC members to guide educational priorities and resource development.
Three-Year Strategic Roadmap
Year 1 – Listening & Landscape Assessment
  • Conduct interviews and moderated spring session
  • Launch survey to validate key challenges
  • Prioritize focus areas and plan toolkits
Year 2 – Toolkit Development & Education Planning
  • Create implementation resources for clinical teams
  • Identify educational gaps and opportunities
Year 3 – Programmatic Rollout & Strategic Expansion
  • Roll out educational tools (e.g., webinars, workshops)
  • Explore navigator training and communication tools
  • Facilitate peer learning and data-sharing
Benefits of Industry Participation
  • Collaborate directly with leading AUA clinicians
  • Gain insights into national trends and barriers
  • Shape the roadmap for precision care in urology
  • Receive early access to needs assessment and AUA-developed solutions
AUA Member Education Dissemination Plan
Over the course of three years, the AUAPMC aims to implement a physician education dissemination plan focused on integrating precision medicine into urologic care. This includes raising awareness of biomarker-guided and genomically informed strategies, supporting clinical decision-making, and addressing implementation challenges. These efforts will help improve outcomes and promote equitable access across practice settings.
2026 Industry Membership
$50K per 2 seats/year (annual membership)
AUAPMC remains a member-driven initiative—its direction and deliverables will reflect the insights, goals, and collaboration of the full collective.